Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A conditional feedback loop regulates Ras activity through EphA2.

Madhu Macrae1, Richard M Neve, Pablo Rodriguez-Viciana

  • 1Cancer Research Institute and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94143, USA.

Cancer Cell
|August 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS<sup>G12C</sup> suppresses PI3Kα and leads to potent tumor inhibition.

bioRxiv : the preprint server for biology·2026
Same author

Revisiting RAS family GTPase signaling: effector selectivity and oncogenic bypass.

The Biochemical journal·2026
Same author

Dashboard Knee: Injury Mechanisms, Diagnostic Challenges, and Treatment Outcomes.

Cureus·2026
Same author

The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug design.

Biological chemistry·2026
Same author

Disulfide tethering reveals cryptic pockets in oncogenic KRAS.

Communications chemistry·2026
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

The EphA2 receptor tyrosine kinase, often overexpressed in cancers like breast cancer, forms a negative feedback loop with the Ras-Raf-MAPK pathway to regulate cell growth. This interaction

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • EphA2 receptor tyrosine kinase is overexpressed in numerous cancers, notably 40% of breast cancers.
  • The Ras-Raf-MAPK pathway is a critical signaling cascade involved in cell proliferation and survival.

Purpose of the Study:

  • To investigate the regulatory relationship between EphA2 and the Ras-Raf-MAPK pathway.
  • To elucidate the role of EphA2 and its ligand ephrin-A1 in breast cancer cell lines.

Main Methods:

  • Analysis of EphA2 as a direct transcriptional target of the Ras-Raf-MAPK pathway.
  • Assessment of ligand-stimulated EphA2's effect on Ras activation.
  • Examination of EphA2 and ephrin-A1 expression patterns in breast cancer cell lines.

Related Experiment Videos

Main Results:

  • EphA2 is a direct transcriptional target of the Ras-Raf-MAPK pathway, forming a negative feedback loop that attenuates Ras activity.
  • Expression of EphA2 and its ligand ephrin-A1 is mutually exclusive in breast cancer cell lines.
  • The MAPK pathway inhibits ephrin-A1 expression, while ephrin-A1 expression inhibits EphA2 levels, creating a reciprocal expression pattern.

Conclusions:

  • The EphA2-Ras-Raf-MAPK signaling axis and its reciprocal receptor-ligand expression pattern play a significant role in cancer development.
  • Disruption of this negative feedback loop may contribute to oncogenesis.